Mallinckrodt Announces Publication of Real-World Data from Retrospective Study on the Investigational Use of Inhaled Nitric Oxide in Hospitalized COVID-19 Patients

/PRNewswire/ -- Mallinckrodt plc (OTCMKTS:MNKKQ), a global biopharmaceutical company, today announced the publication of findings from a retrospective chart...

Related Keywords

Colorado ,United States ,Dublin ,Ireland ,Berlin ,Germany ,Steven Romano ,Steve Abman ,Danielj Speciale ,Prnewswire Mallinckrodt ,Heather Guzzi ,Exchange Commission ,Mallinckrodt Pharmaceuticals ,University Of Colorado ,Company Inomax ,Green Room Communications ,Drug Administration ,Important Safety Information ,Clinical Global Impression ,Executive Vice President ,Chief Scientific Officer ,Nitric Oxide Delivery ,Full Prescribing ,Specialty Brands ,Specialty Generics ,Investor Relations ,Annual Report ,Vice President ,Green Room ,Online March ,Mallinckrodt Plc ,